UCB SA (UCB.BR)

EUR 187.45

(0.83%)

Net Income Summary of UCB SA

  • UCB SA's latest annual net income in 2023 was 343 Million EUR , down -17.94% from previous year.
  • UCB SA's latest quarterly net income in 2024 Q2 was 208 Million EUR , down 0.0% from previous quarter.
  • UCB SA reported an annual net income of 418 Million EUR in 2022, down -60.49% from previous year.
  • UCB SA reported an annual net income of 1.05 Billion EUR in 2021, up 44.54% from previous year.
  • UCB SA reported a quarterly net income of 311 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly net income of 343 Million EUR for 2023 FY, down -17.94% from previous quarter.

Annual Net Income Chart of UCB SA (2023 - 2002)

Historical Annual Net Income of UCB SA (2023 - 2002)

Year Net Income Net Income Growth
2023 343 Million EUR -17.94%
2022 418 Million EUR -60.49%
2021 1.05 Billion EUR 44.54%
2020 732 Million EUR -7.58%
2019 792 Million EUR -1.0%
2018 800 Million EUR 6.24%
2017 753 Million EUR 44.81%
2016 520 Million EUR 96.97%
2015 264 Million EUR 129.57%
2014 115 Million EUR 40.24%
2013 82 Million EUR -67.97%
2012 256 Million EUR 8.94%
2011 235 Million EUR 125.96%
2010 104 Million EUR -79.77%
2009 514 Million EUR 1095.35%
2008 43 Million EUR -73.29%
2007 161 Million EUR -56.13%
2006 367 Million EUR -51.39%
2005 755 Million EUR 107.97%
2004 363.04 Million EUR 6.88%
2003 339.67 Million EUR 2.37%
2002 331.81 Million EUR 0.0%

Peer Net Income Comparison of UCB SA

Name Net Income Net Income Difference
ABIONYX Pharma SA -3.51 Million EUR 9849.858%
ABIVAX Société Anonyme -147.74 Million EUR 332.165%
Adocia SA -21.16 Million EUR 1720.83%
Aelis Farma SA -5.07 Million EUR 6854.628%
Biophytis S.A. -17.02 Million EUR 2114.566%
Advicenne S.A. -7.03 Million EUR 4978.396%
genOway Société anonyme 1.56 Million EUR -21780.931%
IntegraGen SA -171.39 Thousand EUR 200217.854%
Medesis Pharma S.A. -3.95 Million EUR 8762.73%
Neovacs S.A. -8.74 Million EUR 4022.937%
NFL Biosciences SA -3.74 Million EUR 9257.715%
Plant Advanced Technologies SA 79.16 Thousand EUR -433150.388%
Quantum Genomics Société Anonyme -3.17 Million EUR 10916.958%
Sensorion SA -22.06 Million EUR 1654.611%
Theranexus Société Anonyme -6.82 Million EUR 5123.468%
TME Pharma N.V. -6.73 Million EUR 5192.043%
Valbiotis SA -7.36 Million EUR 4755.266%
TheraVet SA -1.57 Million EUR 21937.3%
Valerio Therapeutics Société anonyme -20.34 Million EUR 1786.001%
argenx SE -272.91 Million EUR 225.68%
BioSenic S.A. -28.77 Million EUR 1291.883%
Celyad Oncology SA -8.44 Million EUR 4160.133%
DBV Technologies S.A. -67.26 Million EUR 609.89%
Galapagos NV 211.69 Million EUR -62.024%
Genfit S.A. -28.89 Million EUR 1287.098%
GeNeuro SA -14.75 Million EUR 2424.321%
Hyloris Pharmaceuticals SA -15.38 Million EUR 2330.169%
Innate Pharma S.A. -7.57 Million EUR 4631.044%
Inventiva S.A. -110.42 Million EUR 410.615%
MaaT Pharma SA -19.71 Million EUR 1839.616%
MedinCell S.A. -25.03 Million EUR 1469.918%
Nanobiotix S.A. -39.7 Million EUR 963.98%
Onward Medical N.V. -36.18 Million EUR 1048.011%
Oryzon Genomics S.A. -3.35 Million EUR 10329.819%
OSE Immunotherapeutics SA -23 Million EUR 1591.11%
Oxurion NV -18.96 Million EUR 1908.213%
Pharming Group N.V. -9.75 Million EUR 3615.573%
Poxel S.A. -35.09 Million EUR 1077.486%
GenSight Biologics S.A. -26.22 Million EUR 1408.162%
Transgene SA -22.32 Million EUR 1636.188%
Financière de Tubize SA 88.15 Million EUR -289.104%
Valneva SE -101.42 Million EUR 438.168%
Vivoryon Therapeutics N.V. -28.34 Million EUR 1310.218%